Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.

Khouri, I F

Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL. [electronic resource] - Bone marrow transplantation Jan 2017 - 28-33 p. digital

Publication Type: Comparative Study; Journal Article

1476-5365

10.1038/bmt.2016.204 doi


Adult
Aged
Bendamustine Hydrochloride--administration & dosage
Cyclophosphamide--administration & dosage
Disease-Free Survival
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--mortality
Male
Middle Aged
Rituximab--administration & dosage
Survival Rate
Transplantation Conditioning--methods
Vidarabine--administration & dosage